Guardant Health, Inc. (GH)
118.95
+0.94
(+0.80%)
USD |
NASDAQ |
May 22, 16:00
118.84
-0.11
(-0.09%)
After-Hours: 20:00
Guardant Health EPS Diluted (Quarterly) : -0.8538 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.241 |
| Labcorp Holdings, Inc. | 3.351 |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | -0.8039 |
| Castle Biosciences, Inc. | -0.4859 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -112.08M |
| Revenue (Quarterly) | 301.66M |
| Total Expenses (Quarterly) | 413.74M |
| Enterprise Value | 16.37B |
| Gross Profit Margin (Quarterly) | 65.22% |
| Profit Margin (Quarterly) | -37.15% |
| Earnings Yield | -2.86% |
| Normalized Earnings Yield | -2.794 |